This observation raises the possibility that more intensive insulin therapy, often required in patients with advanced DN, could be linked to higher PTX3 levels, either as a reflection of disease severity or a potential pro-inflammatory effect of insulin. The gene discussed is INS; the disease is liver dysplastic nodule.